Viatris Inc.

VTRS Healthcare Drug Manufacturers Specialty & Generic

Viatris Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.3 billion, down 2.98% from fiscal 2024. In the quarter to June 2026, revenue grew 4.88%, EPS fell 2,464.1%, free cash flow grew 101.1% and total debt fell 18.1%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years.

18.66 0.44 +2.41%
Market cap
$20.9B
P/E
0.0×
Fwd P/E
61.1×
Dividend yield
2.57%
F-score
4/9
Altman Z
0.61
Beneish M
−3.29
Dividend safety
37/100

Viatris Inc. (VTRS) EV/FCF

Alert me on EV/FCF

As of 16 October 2026, Viatris Inc. (VTRS) trades at a EV/FCF of 18.1×. Over the past ten years it has ranged from 5.7× (March 2025) to 171× (July 2015); the current reading is higher than 48% of that period.

EV/FCF, daily

Embed this chart

Annual newest first

Period EV/FCF Change
FY2025 14.3× 111.64%
FY2024 6.7× (38.65%)
FY2023 11.0× (11.21%)
FY2022 12.4× (19.30%)
FY2021 15.3× (78.12%)
FY2020 70.1× 323.96%
FY2019 16.5× (29.51%)
FY2018 23.5× (23.92%)
FY2017 30.8× 11.17%
FY2016 27.7× (0.24%)

Quarterly newest first

Period EV/FCF Change
Jun 2026 16.4× 0.08%
Mar 2026 16.4× 14.60%
Dec 2025 14.3× (12.87%)
Sep 2025 16.4× 122.75%
42 more quarters

Against its own ten years

Low 5.7× High 171×
Ten-year median 19.9×
Current reading's percentile 53

EV/FCF against peers

What EV/FCF is

EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))

The full definition of EV/FCF →

More on VTRS